Study Type/Subtype |
Ongoing |
Reported but Not Published |
Published |
(catch all category) |
Behavior, Neurochemistry, Neuropathology |
0 |
0 |
2 |
Driving and Vehicular Crash Studies |
0 |
0 |
2 |
Insects |
0 |
0 |
10 |
Category Total |
0 |
0 |
14 |
Engineering & Physics |
5G |
1 |
0 |
2 |
Antenna |
1 |
0 |
0 |
Auditory Pathology & RF Hearing |
0 |
0 |
2 |
Body area network systems |
1 |
0 |
0 |
Computational Dosimetry & Experimental Models of Humans |
6 |
2 |
77 |
Computational Dosimetry in Animals |
1 |
0 |
5 |
Computational Dosimetry in Cell Culture |
0 |
0 |
11 |
Computational Dosimetry Methods |
0 |
0 |
17 |
Dielectrometry, Spectroscopy & Tissue Parameters |
3 |
0 |
44 |
Electromagnetic Interference & Compatibility |
5 |
8 |
68 |
Experimental Dosimetry in Animals |
0 |
1 |
10 |
Experimental Dosimetry in Humans |
2 |
0 |
0 |
Exposure Systems - Animals |
1 |
0 |
4 |
Exposure Systems - Cell Culture |
0 |
0 |
5 |
Eye Pathology |
0 |
0 |
1 |
Hearing Aid Compatibility (HAC) |
0 |
0 |
36 |
Induced Current, Contact Current |
0 |
0 |
8 |
Instrumentation |
0 |
0 |
1 |
Membrane Biochemistry, Fluidity, Electroporation |
0 |
0 |
3 |
RF / ELF Emissions Measurements |
7 |
3 |
34 |
RF Measurement Techniques |
0 |
0 |
3 |
RF Therapy (e.g., Diathermy, Anticancer Drug Delivery, Tissue Ablation) |
0 |
0 |
10 |
Shielding methods & products for EMF |
0 |
0 |
2 |
Signaling (Ca++/Ion Efflux, Neuron Conduction/channels, Muscle Contraction) |
0 |
0 |
1 |
Standards, Expert Reviews, Regulatory Guidelines |
0 |
0 |
1 |
Temperature and RF Exposure |
1 |
0 |
2 |
Theoretical Mechanisms |
3 |
1 |
137 |
Thermoregulation and Time-Temperature Thresholds |
0 |
0 |
16 |
Wireless energy transfer |
0 |
0 |
1 |
Category Total |
32 |
15 |
501 |
Epidemiology |
Auditory Pathology & RF Hearing |
0 |
0 |
3 |
Behavior, Neurochemistry, Neuropathology |
1 |
0 |
21 |
Biochemical endpoints (general) |
0 |
0 |
1 |
Blood Brain Barrier, Brain Circulation |
0 |
0 |
5 |
Blood Pressure, Heart Rate, Circulation, and Respiratory Rate |
0 |
0 |
2 |
Bone and Wound Healing, Analgesia, Clinical Use |
0 |
0 |
2 |
Case Control Cancer Study |
11 |
0 |
217 |
Case Study of a Patient(s) |
0 |
0 |
23 |
Cognitive Function & Memory |
0 |
0 |
11 |
Cohort (Geographical Correlation) |
1 |
0 |
50 |
Cohort Cancer Study |
8 |
4 |
84 |
DNA Breaks, Repair, & Mutation |
0 |
0 |
1 |
EEG, Event Related Potentials, Sleep Disturbances |
2 |
0 |
28 |
Experimental Dosimetry in Humans |
2 |
0 |
19 |
Eye Pathology |
1 |
0 |
22 |
Hematology & Immune Function |
0 |
0 |
6 |
Hormone Changes |
0 |
0 |
2 |
Micronuclei & Chromosome Aberrations |
0 |
0 |
9 |
Oxidative Stress |
0 |
0 |
3 |
Risk Analysis/Communication (Catch All) |
0 |
0 |
3 |
Risk Perception, Mobile Phone Use Patterns |
0 |
0 |
33 |
Salivary (Parotid) Gland |
0 |
0 |
2 |
Subjective Symptoms (e.g., Headaches, Hypersensitivity, Fatigue) |
2 |
2 |
115 |
Teratogenicity, Reproduction, & Development |
1 |
0 |
57 |
Vehicular Accident Study |
0 |
2 |
28 |
Well being and mobile phone use |
0 |
0 |
1 |
Category Total |
29 |
8 |
748 |
Human / Provocation |
Auditory Pathology & RF Hearing |
6 |
0 |
55 |
Behavior, Neurochemistry, Neuropathology |
0 |
0 |
13 |
Biochemical endpoints (general) |
0 |
0 |
6 |
Blood Brain Barrier, Brain Circulation |
2 |
0 |
10 |
Blood Pressure, Heart Rate, Circulation, and Respiratory Rate |
1 |
1 |
37 |
Bone and Wound Healing, Analgesia, Clinical Use |
0 |
0 |
1 |
Case Study of a Patient(s) |
0 |
0 |
2 |
Cognitive Function & Memory |
4 |
2 |
55 |
Dielectrometry, Spectroscopy & Tissue Parameters |
0 |
0 |
1 |
DNA Breaks, Repair, & Mutation |
1 |
0 |
4 |
EEG, Event Related Potentials, Sleep Disturbances |
6 |
10 |
142 |
Ergonomics |
0 |
0 |
1 |
Experimental Dosimetry in Humans |
0 |
0 |
1 |
Eye Pathology |
1 |
1 |
4 |
Gene Expression, Protein Activity |
0 |
0 |
3 |
Hearing Aid Compatibility (HAC) |
0 |
0 |
2 |
Hematology & Immune Function |
1 |
0 |
9 |
Hormone Changes |
1 |
0 |
10 |
Micronuclei & Chromosome Aberrations |
0 |
0 |
9 |
Oxidative Stress |
0 |
1 |
3 |
Pain |
0 |
0 |
1 |
RF Therapy (e.g., Diathermy, Anticancer Drug Delivery, Tissue Ablation) |
0 |
0 |
2 |
Risk Analysis/Communication (Catch All) |
0 |
0 |
20 |
Risk Perception, Mobile Phone Use Patterns |
0 |
0 |
2 |
Salivary (Parotid) Gland |
0 |
0 |
6 |
Signaling (Ca++/Ion Efflux, Neuron Conduction/channels, Muscle Contraction) |
0 |
2 |
0 |
Subjective Symptoms (e.g., Headaches, Hypersensitivity, Fatigue) |
3 |
1 |
98 |
Temperature and RF Exposure |
0 |
0 |
3 |
Teratogenicity, Reproduction, & Development |
2 |
0 |
18 |
Theoretical Mechanisms |
0 |
0 |
6 |
Thermoregulation and Time-Temperature Thresholds |
1 |
0 |
36 |
Vehicular Accident Study |
0 |
0 |
15 |
Well being and mobile phone use |
0 |
0 |
1 |
Category Total |
29 |
18 |
576 |
In Situ |
Birds |
0 |
0 |
1 |
Growth Rate, Cell Cycle, Apoptosis |
0 |
0 |
2 |
Category Total |
0 |
0 |
3 |
In Vitro |
5G |
0 |
0 |
4 |
Bacteria/Yeast |
0 |
0 |
6 |
Behavior, Neurochemistry, Neuropathology |
0 |
1 |
9 |
Biochemical endpoints (general) |
0 |
0 |
15 |
Blood Brain Barrier, Brain Circulation |
1 |
0 |
7 |
Blood Pressure, Heart Rate, Circulation, and Respiratory Rate |
0 |
0 |
12 |
Cancer therapy (RF/EMF) |
0 |
0 |
1 |
Co-exposure of RFR and other agents |
0 |
0 |
3 |
Dielectrometry, Spectroscopy & Tissue Parameters |
0 |
0 |
3 |
Differentiation (cellular) |
0 |
0 |
1 |
DNA Breaks, Repair, & Mutation |
3 |
6 |
101 |
EEG, Event Related Potentials, Sleep Disturbances |
0 |
0 |
6 |
Eye Pathology |
0 |
0 |
16 |
Gene Expression, Protein Activity |
10 |
7 |
196 |
Growth Rate, Cell Cycle, Apoptosis |
4 |
12 |
155 |
Hematology & Immune Function |
1 |
0 |
43 |
Hormone Changes |
0 |
0 |
2 |
Instrumentation |
0 |
0 |
1 |
Membrane Biochemistry, Fluidity, Electroporation |
3 |
1 |
53 |
Micronuclei & Chromosome Aberrations |
3 |
2 |
85 |
Oxidative Stress |
5 |
0 |
38 |
Pharmacokinetics/ Pharmacodynamics |
0 |
0 |
3 |
Plants/Trees |
0 |
0 |
2 |
RF Measurement Techniques |
0 |
0 |
2 |
Signaling (Ca++/Ion Efflux, Neuron Conduction/channels, Muscle Contraction) |
3 |
2 |
90 |
Temperature and RF Exposure |
0 |
0 |
4 |
Temperature Sensitive Polymer Structures |
0 |
0 |
2 |
Teratogenicity, Reproduction, & Development |
1 |
0 |
28 |
Theoretical Mechanisms |
0 |
0 |
4 |
Thermoregulation and Time-Temperature Thresholds |
0 |
0 |
13 |
Transformation |
1 |
1 |
8 |
Category Total |
35 |
32 |
913 |
In Vivo |
Auditory Pathology & RF Hearing |
0 |
0 |
49 |
Behavior, Neurochemistry, Neuropathology |
7 |
4 |
374 |
Biochemical endpoints (general) |
0 |
0 |
29 |
Birds |
0 |
0 |
9 |
Blood Brain Barrier, Brain Circulation |
3 |
1 |
77 |
Blood Pressure, Heart Rate, Circulation, and Respiratory Rate |
0 |
0 |
35 |
Bone and Wound Healing, Analgesia, Clinical Use |
1 |
0 |
11 |
Cancer Studies in Animals Short-Term |
0 |
0 |
8 |
Chemical-Radiation-Genetically Initiated Tumor Bioassay |
0 |
1 |
34 |
Co-exposure of RFR and other agents |
0 |
0 |
16 |
Cognitive Function & Memory |
0 |
0 |
15 |
DNA Breaks, Repair, & Mutation |
0 |
3 |
57 |
EEG, Event Related Potentials, Sleep Disturbances |
1 |
1 |
30 |
Experimental Dosimetry in Animals |
0 |
0 |
1 |
Eye Pathology |
0 |
0 |
56 |
Gene Expression, Protein Activity |
1 |
2 |
64 |
Growth Rate, Cell Cycle, Apoptosis |
0 |
0 |
22 |
Hematology & Immune Function |
0 |
1 |
152 |
Hormone Changes |
2 |
4 |
20 |
Insects |
0 |
0 |
5 |
Long Term Animal Bioassay |
2 |
3 |
47 |
Membrane Biochemistry, Fluidity, Electroporation |
0 |
0 |
2 |
Micronuclei & Chromosome Aberrations |
1 |
1 |
25 |
Oxidative Stress |
2 |
1 |
122 |
Pharmacokinetics/ Pharmacodynamics |
0 |
0 |
1 |
Signaling (Ca++/Ion Efflux, Neuron Conduction/channels, Muscle Contraction) |
1 |
1 |
18 |
Temperature and RF Exposure |
0 |
0 |
3 |
Temperature Sensitive Polymer Structures |
1 |
0 |
0 |
Teratogenicity, Reproduction, & Development |
1 |
2 |
247 |
Theoretical Mechanisms |
0 |
0 |
1 |
Thermoregulation and Time-Temperature Thresholds |
0 |
0 |
159 |
Tumor Cell Line Injection Bioassay |
0 |
0 |
6 |
Windows (frequency, amplitude) |
0 |
0 |
1 |
Category Total |
23 |
25 |
1696 |
Literature Review, Letter, Book Chapt., Report |
Auditory Pathology & RF Hearing |
0 |
0 |
1 |
Cancer therapy (RF/EMF) |
0 |
0 |
1 |
Case Control Cancer Study |
0 |
0 |
1 |
Co-exposure of RFR and other agents |
0 |
0 |
1 |
Electromagnetic Interference & Compatibility |
0 |
0 |
1 |
Growth Rate, Cell Cycle, Apoptosis |
0 |
0 |
1 |
Literature Review or Letter to Editor |
3 |
2 |
12 |
Non-Peer Reviewed Reports and Book Chapters |
0 |
0 |
9 |
Oxidative Stress |
0 |
0 |
1 |
Signaling (Ca++/Ion Efflux, Neuron Conduction/channels, Muscle Contraction) |
0 |
0 |
1 |
Standards, Expert Reviews, Regulatory Guidelines |
0 |
0 |
12 |
Teratogenicity, Reproduction, & Development |
0 |
0 |
6 |
Category Total |
3 |
2 |
47 |
Plant Studies |
Biochemical endpoints (general) |
0 |
0 |
1 |
Gene Expression, Protein Activity |
1 |
0 |
1 |
Growth Rate, Cell Cycle, Apoptosis |
0 |
1 |
15 |
Literature Review or Letter to Editor |
0 |
0 |
2 |
Membrane Biochemistry, Fluidity, Electroporation |
0 |
1 |
0 |
Micronuclei & Chromosome Aberrations |
0 |
1 |
2 |
Plants/Trees |
1 |
0 |
4 |
Signaling (Ca++/Ion Efflux, Neuron Conduction/channels, Muscle Contraction) |
0 |
1 |
0 |
Category Total |
2 |
4 |
25 |
Social Sciences |
Industry Bias |
0 |
0 |
2 |
Risk Analysis/Communication (Catch All) |
0 |
0 |
1 |
Risk Perception, Mobile Phone Use Patterns |
6 |
1 |
75 |
Well being and mobile phone use |
0 |
0 |
30 |
Category Total |
6 |
1 |
108 |
Grand Total |
159 |
105 |
4631 |